These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8066934)

  • 1. [Intranasal glucagon in the treatment of hypoglycemia. A therapeutic possibility in the future].
    Carstens S; Andersen I
    Ugeskr Laeger; 1994 Jul; 156(30):4339-42. PubMed ID: 8066934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehospital treatment of severe hypoglycaemia: a comparison of intramuscular glucagon and intravenous glucose.
    Carstens S; Sprehn M
    Prehosp Disaster Med; 1998; 13(2-4):44-50. PubMed ID: 10346406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful administration of intranasal glucagon in the out-of-hospital environment.
    Sibley T; Jacobsen R; Salomone J
    Prehosp Emerg Care; 2013; 17(1):98-102. PubMed ID: 22971130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic coma and hypoglycemia in children. What to do when in an emergency].
    Riedl B
    MMW Fortschr Med; 2004 Oct; 146(43):49-51. PubMed ID: 15559520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.
    Freychet L; Rizkalla SW; Desplanque N; Basdevant A; Zirinis P; Tchobroutsky G; Slama G
    Lancet; 1988 Jun; 1(8599):1364-6. PubMed ID: 2898045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.
    Pontiroli AE
    J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
    Pontiroli AE; Ceriani V
    Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
    Hoff AO; Vassilopoulou-Sellin R
    Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients.
    Pontiroli AE; Calderara A; Pajetta E; Alberetto M; Pozza G
    Diabetes Care; 1989 Oct; 12(9):604-8. PubMed ID: 2676430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients With Diabetes: A Systematic Review.
    Singh-Franco D; Moreau C; Levin AD; Rosa D; Johnson M
    Clin Ther; 2020 Sep; 42(9):e177-e208. PubMed ID: 32873417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nasal administration of glucagon in the treatment of neonatal hypoglycemia].
    Fabris C; Licata D; Garzena E; Stasiowska B; Desalvo L; Mombrò M; Trapani G
    Minerva Pediatr; 1984 May; 36(10):525-8. PubMed ID: 6482853
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
    Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
    Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
    Rickels MR; Ruedy KJ; Foster NC; Piché CA; Dulude H; Sherr JL; Tamborlane WV; Bethin KE; DiMeglio LA; Wadwa RP; Ahmann AJ; Haller MJ; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Feb; 39(2):264-70. PubMed ID: 26681725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon.
    Slama G; Alamowitch C; Desplanque N; Letanoux M; Zirinis P
    Diabetologia; 1990 Nov; 33(11):671-4. PubMed ID: 2076798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
    Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.